Literature DB >> 27195245

Hyperuricemia, Cardiovascular Disease, and Hypertension.

Masanari Kuwabara1.   

Abstract

In recent years, there has been an increase in the prevalence of hyperuricemia, and the latter has attracted attention as an adult lifestyle-associated disease, together with hypertension, diabetes, and dyslipidemia. Although hyperuricemia is known to be an independent risk factor for hypertension, whether it is an independent risk factor for cardiovascular disease remains controversial. Recently, some small-scale interventional studies on antihyperuricemic medications showed that the latter improved angina symptoms and prevented cardiovascular disease. Here, we will mainly explain the cause of hyperuricemia and the associations between hyperuricemia, hypertension, and cardiovascular disease based on the latest published evidence.

Entities:  

Keywords:  Cardiovascular disease; Hypertension; Risk factor; Uric acid; Uric acid transporter

Year:  2016        PMID: 27195245      PMCID: PMC4865070          DOI: 10.1159/000443769

Source DB:  PubMed          Journal:  Pulse (Basel)        ISSN: 2235-8668


  35 in total

1.  Relationships among hyperuricemia, metabolic syndrome, and endothelial function.

Authors:  Hirofumi Tomiyama; Yukihito Higashi; Bonpei Takase; Kohichi Node; Masataka Sata; Teruo Inoue; Yutaka Ishibashi; Shinichiro Ueda; Kenei Shimada; Akira Yamashina
Journal:  Am J Hypertens       Date:  2011-04-14       Impact factor: 2.689

2.  Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study.

Authors:  B F Culleton; M G Larson; W B Kannel; D Levy
Journal:  Ann Intern Med       Date:  1999-07-06       Impact factor: 25.391

3.  Hyperuricaemia, chronic kidney disease, and outcomes in heart failure: potential mechanistic insights from epidemiological data.

Authors:  Gerasimos S Filippatos; Mustafa I Ahmed; James D Gladden; Marjan Mujib; Inmaculada B Aban; Thomas E Love; Paul W Sanders; Bertram Pitt; Stefan D Anker; Ali Ahmed
Journal:  Eur Heart J       Date:  2011-01-03       Impact factor: 29.983

4.  Relation between serum uric acid and risk of cardiovascular disease in essential hypertension. The PIUMA study.

Authors:  P Verdecchia; G Schillaci; G Reboldi; F Santeusanio; C Porcellati; P Brunetti
Journal:  Hypertension       Date:  2000-12       Impact factor: 10.190

5.  Associations of serum uric acid levels with arterial wave reflections and central systolic blood pressure.

Authors:  Pai-Feng Hsu; Shao-Yuan Chuang; Hao-Min Cheng; Shih-Hsien Sung; Chih-Tai Ting; Edward G Lakatta; Frank C P Yin; Pesus Chou; Chen-Huan Chen
Journal:  Int J Cardiol       Date:  2013-02-27       Impact factor: 4.164

6.  Effect of high-dose allopurinol on exercise in patients with chronic stable angina: a randomised, placebo controlled crossover trial.

Authors:  Awsan Noman; Donald S C Ang; Simon Ogston; Chim C Lang; Allan D Struthers
Journal:  Lancet       Date:  2010-06-09       Impact factor: 79.321

7.  Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial.

Authors:  Marvin A Konstam; James D Neaton; Kenneth Dickstein; Helmut Drexler; Michel Komajda; Felipe A Martinez; Gunter A J Riegger; William Malbecq; Ronald D Smith; Soneil Guptha; Philip A Poole-Wilson
Journal:  Lancet       Date:  2009-11-16       Impact factor: 79.321

Review 8.  Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease.

Authors:  Richard J Johnson; Mark S Segal; Yuri Sautin; Takahiko Nakagawa; Daniel I Feig; Duk-Hee Kang; Michael S Gersch; Steven Benner; Laura G Sánchez-Lozada
Journal:  Am J Clin Nutr       Date:  2007-10       Impact factor: 7.045

9.  Uric acid reduction rectifies prehypertension in obese adolescents.

Authors:  Beth Soletsky; Daniel I Feig
Journal:  Hypertension       Date:  2012-09-24       Impact factor: 10.190

Review 10.  Effect of allopurinol on blood pressure: a systematic review and meta-analysis.

Authors:  Vikram Agarwal; Nidhi Hans; Franz H Messerli
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-08-20       Impact factor: 3.738

View more
  32 in total

Review 1.  Hyperuricemia, Type 2 Diabetes Mellitus, and Hypertension: an Emerging Association.

Authors:  Ibrahim Mortada
Journal:  Curr Hypertens Rep       Date:  2017-09       Impact factor: 5.369

2.  Uric Acid Is a Strong Risk Marker for Developing Hypertension From Prehypertension: A 5-Year Japanese Cohort Study.

Authors:  Masanari Kuwabara; Ichiro Hisatome; Koichiro Niwa; Shigeko Hara; Carlos A Roncal-Jimenez; Petter Bjornstad; Takahiko Nakagawa; Ana Andres-Hernando; Yuka Sato; Thomas Jensen; Gabriela Garcia; Bernardo Rodriguez-Iturbe; Minoru Ohno; Miguel A Lanaspa; Richard J Johnson
Journal:  Hypertension       Date:  2017-12-04       Impact factor: 10.190

3.  Protective Effects of α-Lipoic Acid on Vascular Oxidative Stress in Rats with Hyperuricemia.

Authors:  Wei Xiang; Li Wang; Shi Cheng; Yong Zhou; Ling Ma
Journal:  Curr Med Sci       Date:  2019-12-16

4.  Elevated Serum Uric Acid Level Predicts Rapid Decline in Kidney Function.

Authors:  Masanari Kuwabara; Petter Bjornstad; Ichiro Hisatome; Koichiro Niwa; Carlos A Roncal-Jimenez; Ana Andres-Hernando; Thomas Jensen; Tamara Milagres; Yuka Sato; Gabriela Garcia; Minoru Ohno; Miguel A Lanaspa; Richard J Johnson
Journal:  Am J Nephrol       Date:  2017-03-11       Impact factor: 3.754

Review 5.  Does Altered Uric Acid Metabolism Contribute to Diabetic Kidney Disease Pathophysiology?

Authors:  Ambreen Gul; Philip Zager
Journal:  Curr Diab Rep       Date:  2018-03-01       Impact factor: 4.810

6.  "Metabolically Healthy" Obesity and Hyperuricemia Increase Risk for Hypertension and Diabetes: 5-year Japanese Cohort Study.

Authors:  Masanari Kuwabara; Remi Kuwabara; Ichiro Hisatome; Koichiro Niwa; Carlos A Roncal-Jimenez; Petter Bjornstad; Ana Andres-Hernando; Yuka Sato; Thomas Jensen; Gabriela Garcia; Minoru Ohno; James O Hill; Miguel A Lanaspa; Richard J Johnson
Journal:  Obesity (Silver Spring)       Date:  2017-09-18       Impact factor: 5.002

7.  Expression of miR-217 and HIF-1α/VEGF pathway in patients with diabetic foot ulcer and its effect on angiogenesis of diabetic foot ulcer rats.

Authors:  C-J Lin; Y-M Lan; M-Q Ou; L-Q Ji; S-D Lin
Journal:  J Endocrinol Invest       Date:  2019-05-11       Impact factor: 4.256

8.  Asymptomatic Hyperuricemia Without Comorbidities Predicts Cardiometabolic Diseases: Five-Year Japanese Cohort Study.

Authors:  Masanari Kuwabara; Koichiro Niwa; Ichiro Hisatome; Takahiko Nakagawa; Carlos A Roncal-Jimenez; Ana Andres-Hernando; Petter Bjornstad; Thomas Jensen; Yuka Sato; Tamara Milagres; Gabriela Garcia; Minoru Ohno; Miguel A Lanaspa; Richard J Johnson
Journal:  Hypertension       Date:  2017-04-10       Impact factor: 10.190

9.  Effect of allopurinol on the glomerular filtration rate of children with chronic kidney disease.

Authors:  Fatemeh Ghane Sharbaf; Farahnak Assadi
Journal:  Pediatr Nephrol       Date:  2018-03-16       Impact factor: 3.714

Review 10.  Dietary Sodium Intake and Serum Uric Acid: A Mini-Review.

Authors:  Lei Lei; Ji-Guang Wang
Journal:  Pulse (Basel)       Date:  2018-07-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.